| 0HI3 Stock | | | 26.30 4.45 20.37% |
Arrowhead Pharmaceuticals financial indicator trend analysis is way more than just evaluating Arrowhead Pharmaceuticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Arrowhead Pharmaceuticals is a good investment. Please check the relationship between Arrowhead Pharmaceuticals Total Current Liabilities and its Current Deferred Revenue accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Arrowhead Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
For more information on how to buy Arrowhead Stock please use our
How to Invest in Arrowhead Pharmaceuticals guide.
Total Current Liabilities vs Current Deferred Revenue
Total Current Liabilities vs Current Deferred Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Arrowhead Pharmaceuticals Total Current Liabilities account and
Current Deferred Revenue. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Arrowhead Pharmaceuticals' Total Current Liabilities and Current Deferred Revenue is 0.56. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Arrowhead Pharmaceuticals Corp, assuming nothing else is changed. The correlation between historical values of Arrowhead Pharmaceuticals' Total Current Liabilities and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Arrowhead Pharmaceuticals Corp are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Total Current Liabilities i.e., Arrowhead Pharmaceuticals' Total Current Liabilities and Current Deferred Revenue go up and down completely randomly.
Correlation Coefficient | 0.56 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Total Current Liabilities
Total Current Liabilities is an item on Arrowhead Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Arrowhead Pharmaceuticals Corp are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.
Most indicators from Arrowhead Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Arrowhead Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Arrowhead Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
For more information on how to buy Arrowhead Stock please use our
How to Invest in Arrowhead Pharmaceuticals guide.
Selling General Administrative is likely to drop to about 79.1
M in 2024.
Tax Provision is likely to drop to 1,710 in 2024
Arrowhead Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Arrowhead Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Arrowhead Pharmaceuticals fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Arrowhead Stock Analysis
When running Arrowhead Pharmaceuticals' price analysis, check to
measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.